Veracyte
VCYT
125 hedge funds and large institutions have $465M invested in Veracyte in 2018 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 44 reducing their positions, and 11 closing their positions.
127% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 11
37% more capital invested
Capital invested by funds: $340M → $465M (+$125M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
13% more funds holding
Funds holding: 111 → 125 (+14)
0.99% more ownership
Funds ownership: 90.18% → 91.17% (+0.99%)
9% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 44
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $254K
Top Buyers
Top Sellers
VCYT Hedge Fund Activity: Q4 2018 in Review
125 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q4 2018, worth a combined $465M — up 37% from $340M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new VCYT positions and 11 closed out — a net gain of 14 holders — while 40 added to existing stakes and 44 trimmed.
The largest buyer was Assenagon Asset Management, opening a new position worth an estimated $14.4M. The largest seller was Eventide Asset Management, cutting an estimated $14.2M.
- 125 institutional investors held Veracyte (VCYT) as of Q4 2018, up from 111 in Q3 2018.
- Funds reported $465M of Veracyte stock for Q4 2018, up 37% quarter-over-quarter.
- 25 funds opened new Veracyte positions in Q4 2018 and 11 closed out, a net change of +14 holders.
- The largest Veracyte buyer in Q4 2018 was Assenagon Asset Management, an estimated $14.4M added.
- The largest Veracyte seller in Q4 2018 was Eventide Asset Management, an estimated $14.2M sold.
Based on aggregated 13F filings for Q4 2018.